← Back to Search

ABCLO Group for Open Abdomen (AbCLO Trial)

N/A
Recruiting
Led By Mohammed A. Bawazeer, MD
Research Sponsored by Tufts Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Admitted to the trauma and acute care surgery service, underwent damage control laparotomy and left with an open abdomen (OA). Trauma or Emergency General Surgery, such as perforated viscus, Bowel obstruction or abdominal compartment syndrome.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

AbCLO Trial Summary

This trial is testing a new device called the AbCLO (Abdominal Wall Closure) in patients with an open abdomen who had emergency surgery for Trauma or Acute Care Surgery. The study

Who is the study for?
This trial is for patients who have an 'open abdomen' after emergency surgery due to trauma or acute conditions. They should not have been treated with the AbCLO device before and must be compared to past cases at the same center.Check my eligibility
What is being tested?
The study tests if the AbCLO device can improve chances of successfully closing the abdominal wall in open abdomen cases, as opposed to previous methods used (historical controls).See study design
What are the potential side effects?
Since this trial involves a non-invasive device aimed at helping close an open abdomen, side effects may include discomfort, skin irritation around where the device is applied, or potential delays in wound healing.

AbCLO Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had emergency surgery for a severe abdominal issue and was left with an open abdomen.

AbCLO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary facial closure
Secondary outcome measures
Additional procedures/Mesh
Cost comparison
Intensive care Data
+3 more

AbCLO Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ABCLO GroupExperimental Treatment1 Intervention
The cohort (interventional) patients will receive the standard of care (Lahey bag, Ioban and closed suction drains) in addition to the study intervention (AbCLO Device).
Group II: Historical ControlsActive Control1 Intervention
The control group is retrospective patients that were previously managed at the same center, regardless of the technique or the device used to close the OA. At TMC, we have a previously collected data bank of all open abdomen managed at our center. This data bank is approved by IRB. This data bank has 170 patients in total. we will use 45 patients from the data bank to be matched to the interventional group (15 patients) to have a total of 60 patients from TMC. As of LAC+USC Medical Center, they will provide historical controls from the trauma registry.

Find a Location

Who is running the clinical trial?

InentoRR MDUNKNOWN
Tufts Medical CenterLead Sponsor
256 Previous Clinical Trials
255,727 Total Patients Enrolled
LAC+USC Medical CenterOTHER
12 Previous Clinical Trials
31,385 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of individuals participating in this research study?

"Indeed, the details available on clinicaltrials.gov affirm that this medical investigation is actively seeking participants. Initially shared on February 1st, 2024, and last revised on January 29th, 2024, the trial aims to recruit a total of 20 individuals across two specified locations."

Answered by AI

Is the registration process currently ongoing for this clinical trial?

"As per the details on clinicaltrials.gov, this research endeavor is presently in search of suitable candidates. The trial was first made public on February 1st, 2024 and underwent its latest update on January 29th, 2024."

Answered by AI

Is the study open to participants who have reached the age of 50 or older?

"To be eligible for this research study, participants must range in age from 18 to 100 years old."

Answered by AI
~13 spots leftby Dec 2024